151 related articles for article (PubMed ID: 24864143)
1. Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?
López-Basave HN; Morales-Vasquez F; Mendez-Herrera C; Namendys-Silva SA; Luna-Ortiz K; Calderillo-Ruiz G; Cabrera Rojas J; Ruiz-Garcia E; Herrera-Gomez A; Ruiz-Molina JM; Meneses Garcia A
J Oncol; 2014; 2014():307317. PubMed ID: 24864143
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
3. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
[TBL] [Abstract][Full Text] [Related]
4. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details.
Topgül K; Çetinkaya MB; Çiğdem Arslan N; Gül MK; Çan M; Gürsel MF; Erdem D; Malazgirt Z
Ulus Cerrahi Derg; 2015; 31(3):138-47. PubMed ID: 26504417
[TBL] [Abstract][Full Text] [Related]
6. Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: Risk factors for ICU admission and morbidity prognostic score.
Malfroy S; Wallet F; Maucort-Boulch D; Chardonnal L; Sens N; Friggeri A; Passot G; Glehen O; Piriou V
Surg Oncol; 2016 Mar; 25(1):6-15. PubMed ID: 26979635
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico.
López-Basave HN; Morales-Vásquez F; Ruiz Molina JM; González-Enciso A; Namendys-Silva SA; Medina Castro JM; Montalvo-Esquivel G; Herrera-Gómez A; De la Garza Salazar JG
ISRN Oncol; 2011; 2011():526384. PubMed ID: 22091420
[TBL] [Abstract][Full Text] [Related]
8. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Aarts F; Hendriks T; Boerman OC; Koppe MJ; Oyen WJ; Bleichrodt RP
Ann Surg Oncol; 2007 Nov; 14(11):3274-82. PubMed ID: 17653591
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis.
Roh SJ; Park SC; Choi J; Lee JS; Lee DW; Hong CW; Han KS; Park HC; Sohn DK; Oh JH
Ann Coloproctol; 2020 Feb; 36(1):22-29. PubMed ID: 32146785
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
11. Combined modality therapy including cytoreductive surgery and heated intraperitoneal chemotherapy for synchronous low volume peritoneal carcinomatosis from adenocarcinoma of the tail of pancreas in a BRCA-2 carrier resulting in long-term disease-free survival: A case report.
Hoefer RA; Obiora C; Azab B; Harden EA; Kessler JF
Int J Surg Case Rep; 2021 Jun; 83():106047. PubMed ID: 34091215
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and management of toxicity of cytoreductive surgery/hyperthermic intraperitoneal chemotherapy: the initial experience of a single centre study.
Lemstrova R; Flasarova D; Spisarova M; Melichar B; Lovecek M; Havlik R; Neoral C; Mohelnikova-Duchonova B; Klos D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):300-306. PubMed ID: 31435073
[TBL] [Abstract][Full Text] [Related]
13. Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.
Bhagwandin SB; Naffouje S; Salti G
J Surg Oncol; 2015 Mar; 111(3):324-7. PubMed ID: 25557653
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer.
Spiegelberg J; Neeff H; Holzner P; Runkel M; Fichtner-Feigl S; Glatz T
World J Gastrointest Oncol; 2020 Aug; 12(8):903-917. PubMed ID: 32879667
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW
JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
[TBL] [Abstract][Full Text] [Related]
17. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.
Di Leo A; Corvasce A; Weindelmayer J; Mason EJ; Casella F; de Manzoni G
Updates Surg; 2020 Dec; 72(4):1207-1212. PubMed ID: 32410159
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience.
Carboni F; Federici O; Zazza S; Sperduti I; Valle M
Eur J Surg Oncol; 2021 Jan; 47(1):143-148. PubMed ID: 32888734
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery and mitomycin C hyperthermic intraperitoneal chemotherapy with CO
Rotolo S; Di Giorgio A; Santullo F; Attalla El Halabieh M; Lodoli C; Abatini C; Pacelli F
Updates Surg; 2021 Aug; 73(4):1443-1448. PubMed ID: 33782856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
